Vensana Capital — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)
BoardGeoff Pardo(Director)
Board seatKirk Nielsen· per SEC Form D
Co-investorsNew Enterprise Associates (NEA)Treo Ventures, LlcWindham Capital PartnersYsios CapitalHatteras Venture Partners
BiotechGermantown, US
Mukul Jain(Executive Officer)Francine R. Kaufman(Executive Officer, Director)Rick Sullivan(Executive Officer)Kenneth L Horton(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Mirasol Panlilio(Executive Officer)
Board seatPeter Justin Klein· per SEC Form D · $30M raise · filed Sep 2020
Co-investorsNew Enterprise Associates (NEA)
A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Executive Officer, Director, Promoter)Luis A. Diaz, Jr.(Executive Officer, Director, Promoter)Lisa Kann(Executive Officer)Sam Angiuoli(Executive Officer)Felix Dawson(Director)Anthony Newton(Executive Officer)
Board seatJustin Klein· per SEC Form D
Co-investors3B Future Health FundCatalio Capital Management, LPCo-Win VenturesNew Enterprise Associates (NEA)Windham Capital Partners
Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.
Medical DevicesRedwood City, US
Alex DiNello(Executive Officer, Director)
BoardRichard Mott(Director)Brent Ahrens(Director)inJason Lettman(Director)John Ryan(Director)
Board seatJustin Klein· per SEC Form D
Co-investorsCanaan PartnersEmergent Medical Partners, LLPLightstone VenturesNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.